Mycobacterium barrassiaesp. nov., aMycobacterium moriokaenseGroup Species Associated with Chronic Pneumonia

Abstract
Three identical isolates of new rapidly growing mycobacteria (RGM) were recovered from the bronchial aspirate and sputum from a 49-year-old woman presenting with lung lesions. The case met the American Thoracic Society criteria for the diagnosis of nontuberculous mycobacterial infection. The three isolates grew in 3 days at 24 to 42°C. The 16S rRNA gene sequence analysis indicated that the sequences of the isolates were identical and shared 99.7% and 98.1% similarities with those ofMycobacterium moriokaenseandMycobacterium gadium, respectively. Partial 723-bprpoBsequence analyses indicated that the sequences of the isolates shared 95.8% and 92.3% similarities with those ofM. moriokaenseandM. gadium, respectively. Polyphasic identification (including biochemical tests; antimicrobial susceptibility profiling; andhsp65,recA, andsodAgene sequence analyses, as well as G+C content determination and cell wall fatty acid composition analysis) supported the evidence that these isolates were representative of a new species. Phylogenetic analyses confirmed the close relationships of the isolates withM. moriokaenseand the definedM. moriokaensegroup. These isolates were susceptible to the antimicrobials currently recommended for the treatment of RGM infections. These isolates differed fromM. moriokaenseby their susceptibility to vancomycin. We propose the nameMycobacterium barrassiaesp. nov. for this new species. The type strain is N7T(CIP 108545Tand CCUG 50398T).

This publication has 50 references indexed in Scilit: